TLR7 and cancer: Additionally, TLR7 has been shown to alter the susceptibility of cancer cells to 30 medicines, with exception of Irofulven, a semi-synthetic analog of the fungal substance illudin S, which has a negative correlation, implying that an increase in TLR7 may result in Irofulven resistance.